1. Home
  2. AERO vs IMCR Comparison

AERO vs IMCR Comparison

Compare AERO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AERO

Grupo Aeromexico S.A.B.

N/A

Current Price

$13.40

Market Cap

2.0B

ML Signal

N/A

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$30.25

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERO
IMCR
Founded
1934
2008
Country
Mexico
United Kingdom
Employees
4084
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
AERO
IMCR
Price
$13.40
$30.25
Analyst Decision
Strong Buy
Buy
Analyst Count
7
12
Target Price
$29.57
$61.82
AVG Volume (30 Days)
637.9K
351.7K
Earning Date
03-02-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
N/A
Revenue
N/A
$249,428,000.00
Revenue This Year
$8.08
$14.39
Revenue Next Year
$5.01
$8.19
P/E Ratio
$7.95
N/A
Revenue Growth
N/A
43.05
52 Week Low
$12.85
$23.15
52 Week High
$23.05
$40.71

Technical Indicators

Market Signals
Indicator
AERO
IMCR
Relative Strength Index (RSI) 29.92 36.52
Support Level N/A N/A
Resistance Level $21.58 $34.86
Average True Range (ATR) 1.11 1.44
MACD -0.34 -0.24
Stochastic Oscillator 8.32 6.80

Price Performance

Historical Comparison
AERO
IMCR

About AERO Grupo Aeromexico S.A.B.

Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: